Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy


Por: Petrucciani N, Carra MC, Martínez-Pérez A, Vitali GC, Landi F, Genova P, Memeo R, Brunetti F, Espin E, Ris F, De'angelis N and EUMARCS Study Group

Publicada: 1 abr 2019
Resumen:
Background/Aim: The aim of this study was to compare the ability of different lymph nodal staging systems to predict cancer recurrence in a multicenter European series of patients who underwent proctectomy after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Patients and Methods: Data on 170 consecutive patients undergoing proctectomy after neoadjuvant therapy for cT3-4 or cN+ rectal adenocarcinoma were retrieved from the European MRI and Rectal Cancer Surgery database. The prognostic role of the number of retrieved and examined nodes, nodal ratio, and log odds of positive lymph nodes (LODDS) was analyzed and compared by receiver operating characteristic curves, Pearson test, and univariate and multivariate analysis. Results: At multivariate analysis, ypN, nodal ratio, and LODDS were all significantly associated with disease-free survival, but LODDS showed the strongest association (hazard ratio(HR)=2.39; 95% confidence interval(CI)=1.05-5.48; p=0.039). Conclusion: LODDS appears to be a useful prognostic indicator in the prediction of disease-free survival of patients undergoing neoadjuvant chemoradiotherapy and proctectomy for locally

Filiaciones:
Petrucciani N:
 Unit of Digestive, Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Henri Mondor Hospital, AP-HP, University of Paris Est, UPEC, Créteil, France

Carra MC:
 Rothschild Hospital, AP-HP, Paris VII University, Paris, France

:
 Unit of Colorectal Surgery, Department of General and Digestive Surgery, Doctor Peset University Hospital, Valencia, Spain

Vitali GC:
 Service of Abdominal Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland

Landi F:
 Unit of Colorectal Surgery, Department of General and Digestive Surgery, University Hospital Vall d'Hebron, Barcelona, Spain

Genova P:
 Unit of Digestive, Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Henri Mondor Hospital, AP-HP, University of Paris Est, UPEC, Créteil, France

Memeo R:
 Department of General Surgery I, F. Miulli Regional General Hospital, Acquaviva delle Fonti, Bari, Italy

Brunetti F:
 Unit of Digestive, Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Henri Mondor Hospital, AP-HP, University of Paris Est, UPEC, Créteil, France

Espin E:
 Unit of Colorectal Surgery, Department of General and Digestive Surgery, University Hospital Vall d'Hebron, Barcelona, Spain

Ris F:
 Service of Abdominal Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland
ISSN: 02507005





ANTICANCER RESEARCH
Editorial
International Institute of Anticancer Research, EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE, Grecia
Tipo de documento: Article
Volumen: 39 Número: 4
Páginas: 2113-2120
WOS Id: 000463619600056
ID de PubMed: 30952757

MÉTRICAS